DPP-4 inhibition has beneficial effects on the heart after myocardial infarction

This publication has 35 references indexed in Scilit:

• Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
  Cardiovascular Diabetology, 2013
• DPP4 Deficiency Exerts Protective Effect against H2O2 Induced Oxidative Stress in Isolated Cardiomyocytes
  PLOS ONE, 2013
• Intestinal CX ₃ C chemokine receptor 1 ^high (CX ₃ CR1 ^high ) myeloid cells prevent T-cell-dependent colitis
  Proceedings of the National Academy of Sciences, 2012
• SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury
  American Journal of Physiology-Heart and Circulatory Physiology, 2011
• Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
  Cardiovascular Diabetology, 2011
• Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice
  Journal of Clinical Investigation, 2010
• Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
  Mediators of Inflammation, 2010
• Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction
  Circulation, 2008
• Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion Injury
  Circulation, 2007
• The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
  Nature, 1998